Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco A Mistretta

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
BJU International|September 24, 2020
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?Giulia Marvaso, Marianna Montesano, Giulia Corrao, et al.
Urologic Oncology|May 21, 2023
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over timeFrancesco A Mistretta, Stefano Luzzago, Sarah Alessi, et al.
Prostate Cancer and Prostatic Diseases|June 29, 2019
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
BJU International|September 18, 2024
Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomesLetizia Maria Ippolita Jannello, Franco Orsi, Stefano Luzzago, et al.
Prostate Cancer and Prostatic Diseases|September 29, 2020
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohortStefano Luzzago, Ottavio de Cobelli, Francesco A Mistretta, et al.
World Journal of Urology|October 23, 2021
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsiesStefano Luzzago, Mattia Luca Piccinelli, Giulia Marvaso, et al.
World Journal of Urology|March 29, 2022
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancerMattia Luca Piccinelli, Stefano Luzzago, Giulia Marvaso, et al.
Prostate Cancer and Prostatic Diseases|December 15, 2019
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
Urologic Oncology|November 24, 2025
Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal massesLetizia Maria Ippolita Jannello, Stefano Luzzago, Mattia Luca Piccinelli, et al.
BJU International|March 10, 2020
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findingsStefano Luzzago, Ottavio de Cobelli, Gabriele Cozzi, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
BJU International|September 24, 2020
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?Giulia Marvaso, Marianna Montesano, Giulia Corrao, et al.
Urologic Oncology|May 21, 2023
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over timeFrancesco A Mistretta, Stefano Luzzago, Sarah Alessi, et al.
Prostate Cancer and Prostatic Diseases|June 29, 2019
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
BJU International|September 18, 2024
Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomesLetizia Maria Ippolita Jannello, Franco Orsi, Stefano Luzzago, et al.
Prostate Cancer and Prostatic Diseases|September 29, 2020
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohortStefano Luzzago, Ottavio de Cobelli, Francesco A Mistretta, et al.
World Journal of Urology|October 23, 2021
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsiesStefano Luzzago, Mattia Luca Piccinelli, Giulia Marvaso, et al.
World Journal of Urology|March 29, 2022
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancerMattia Luca Piccinelli, Stefano Luzzago, Giulia Marvaso, et al.
Prostate Cancer and Prostatic Diseases|December 15, 2019
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-upStefano Luzzago, Michele Catellani, Ettore Di Trapani, et al.
Urologic Oncology|November 24, 2025
Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal massesLetizia Maria Ippolita Jannello, Stefano Luzzago, Mattia Luca Piccinelli, et al.
BJU International|March 10, 2020
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findingsStefano Luzzago, Ottavio de Cobelli, Gabriele Cozzi, et al.
Pageof 10